LONDON - Quoted technology commercialization specialist Puretech Health plc raised £72 million (US$100 million) in a placing, providing funds to advance its wholly owned pipeline of treatments targeting the lymphatic system and to co-invest in upcoming funding rounds for its affiliate companies.